Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7654-7659

  De Bont, E S J M ^a   Guikema, J E J ^a   Scherpen, F ^a   Meeuwsen, T ^a   Kamps, W A ^a   Vellenga, E ^a   Bos, N A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; COMPLEMENTARY DNA; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CANCER MODEL; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIABETES MELLITUS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOMA; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; XENOTRANSPLANTATION;

ANGIOPOIETIN-2; ANIMALS; ANTIGENS, CD34; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LYMPHOKINES; LYMPHOMA, NON-HODGKIN; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED NOD; MICE, SCID; PROTEIN BIOSYNTHESIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035887164     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The biology and clinical uses of blood stem cells
2. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma
3. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia
4. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
5. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
6. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells
7. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
8. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation
9. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8
10. Isolation of putative progenitor endothelial cells for angiogenesis
11. Ischemia- and cytokine-induced mobilization of bone-marrow-derived endothelial progenitor cells for neovascularization
12. Evidence for circulating bone marrow-derived endothelial cells
13. + cells identifies a population of functional endothelial precursors
14. In vitro differentiation of endothelial cells from AC133-positive progenitor cells
15. Mechanisms of angiogenesis
16. Tumor angiogenesis
17. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas
18. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
19. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
20. Evidence of increased angiogenesis in patients with acute myeloid leukemia
21. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
22. Increased bone marrow vascularization in patients with acute myeloid leukaemia: A possible role for vascular endothelial growth factor
23. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF- induced postnatal neovascularization
24. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
25. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
26. Surface IgM-κ specificity on a Burkitt lymphoma cell in vivo and in derived culture lines
27. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects
28. A common precursor for hematopoietic and endothelial cells
29. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
30. Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: Evidence for virus production and endothelial origin
31. The role of circulating cells in the healing of vascular prostheses
32. Circulating activated endothelial cells in sickle cell anemia
33. Origins of circulating endothelial cells and endothelial outgrowth from blood
34. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells